Since February 2023, two UK clinics gradually rolled out three modules — hypertension (HTN), type 2 diabetes (DM2), hypercholesterolemia (HCL) — with a clinical usage that was systematically monitored (by Metadvice) for diagnosis and therapies so that the recommendations can now be linked with observable outcomes (stored by Electronic Medical Record systems, EMR independent from…
DetailsEASD conference, 15 – 19 September 2025 in Vienna. Can we De-Escalate Pharmaco-Therapies For Certain Patients Living with Type 2 Diabetes and Chronic Kidney Disease? Zeina Gabr, Louis-Alexandre Leger, Samia Kidwai, Andrew Krentz, André Jaun Download PDF
DetailsAbstract for the ATTD-Amsterdam conference, 19 – 22 March 2025 in Amsterdam. Integration of Continuous Glucose Monitoring (CGM) Dynamics into an AI-Based Model for Therapeutic Decision Making in Type 2 Diabetes Arina Lozhkina,Zeina Gabr,Camillo Piazza,Maurice Rupp,David Herzig, Lia Bally, André Jaun Download PDF
Details